bromazepam has been researched along with Substance Withdrawal Syndrome in 20 studies
Bromazepam: One of the BENZODIAZEPINES that is used in the treatment of ANXIETY DISORDERS.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cyamemazine is an anxiolytic antipsychotic, which reduces ethanol withdrawal symptoms." | 2.72 | Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome. ( Dib, M; Garay, RP; Garcia-Acosta, S; Kermadi, I; Lemoine, P, 2006) |
| "The severity of withdrawal symptoms was measured using the Clinical Institute Withdrawal Assessment-Benzodiazepines (CIWA-B) questionnaire." | 2.71 | Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression. ( Brunner, H; Friess, E; Holsboer, F; Ising, M; Pedrosa Gil, F; Wichniak, A, 2004) |
| " After four weeks the dosage was reduced in 25% quantities until no further benzodiazepines were taken." | 2.67 | A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. ( Murphy, SM; Tyrer, P, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oulis, P | 1 |
| Masdrakis, VG | 1 |
| Karapoulios, E | 1 |
| Karakatsanis, NA | 1 |
| Kouzoupis, AV | 1 |
| Papadimitriou, GN | 1 |
| Wichniak, A | 1 |
| Brunner, H | 1 |
| Ising, M | 1 |
| Pedrosa Gil, F | 1 |
| Holsboer, F | 1 |
| Friess, E | 1 |
| Lemoine, P | 1 |
| Kermadi, I | 1 |
| Garcia-Acosta, S | 1 |
| Garay, RP | 1 |
| Dib, M | 1 |
| Holtschmidt-Täschner, B | 1 |
| Soyka, M | 1 |
| Böning, J | 1 |
| Ferreri, M | 1 |
| Alby, JM | 1 |
| Chouinard, G | 4 |
| Labonte, A | 1 |
| Fontaine, R | 4 |
| Annable, L | 4 |
| Griffiths, RR | 1 |
| Ator, NA | 1 |
| Lukas, SE | 1 |
| Lamb, RJ | 1 |
| Brady, JV | 1 |
| Louvel, D | 1 |
| Delvaux, M | 1 |
| Larrue, V | 1 |
| Moreau, J | 1 |
| Bonnafous, C | 1 |
| Bueno, L | 1 |
| Frexinos, J | 1 |
| Loeb, P | 1 |
| Adnet, P | 1 |
| Boittiaux, P | 1 |
| Forget, AP | 1 |
| Mille, FX | 1 |
| Fukuda, M | 1 |
| Nakajima, N | 1 |
| Tomita, M | 1 |
| Deuschle, M | 1 |
| Lederbogen, F | 1 |
| Rastogi, RB | 3 |
| Lapierre, YD | 3 |
| Singhal, RL | 3 |
| Agarwal, RA | 1 |
| Murphy, SM | 1 |
| Tyrer, P | 1 |
| Yutrzenka, GJ | 1 |
| Patrick, GA | 1 |
| Rosenberger, W | 1 |
| Beaudry, P | 1 |
| Mercier, P | 1 |
7 trials available for bromazepam and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzodiazepines; | 2004 |
Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Benzodiazepines; Bromazepam; Dose-Response Relationsh | 2006 |
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; C | 1983 |
Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Bromazepam; Clinical Trials as Topic; Diazepam; Doubl | 1984 |
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety Disorders; Bromazepam; Clinical Trials as Topic; | 1984 |
A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence.
Topics: Adult; Anti-Anxiety Agents; Bromazepam; Diazepam; Dose-Response Relationship, Drug; Double-Blind Met | 1991 |
Efficacy and withdrawal of two potent benzodiazepines: bromazepam and lorazepam.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Bromazepam; Clinical Trials as Topic; Double-Blind Me | 1985 |
13 other studies available for bromazepam and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
For publication: Tiagabine in the discontinuation of long-term benzodiazepine use.
Topics: Aged; Anxiety Disorders; Benzodiazepines; Bromazepam; Female; GABA Agonists; Humans; Hypnotics and S | 2009 |
Hyponatremia-induced seizure during carbamazepine treatment.
Topics: Agoraphobia; Anticonvulsants; Benzodiazepines; Bromazepam; Carbamazepine; Dose-Response Relationship | 2007 |
[Bromazepam withdrawal delirium - a psychopharmacological contribution to clinical withdrawal syndromes (author's transl)].
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Bromazepam; Delirium; Dose-Response Relationship, Dru | 1981 |
[Anxiety states and bromazepam (author's transl)].
Topics: Adult; Aged; Alcoholism; Anti-Anxiety Agents; Anxiety Disorders; Bromazepam; Drug Evaluation; Female | 1982 |
Benzodiazepines: drug discrimination and physiological dependence.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Bromazepam; Diazepam; Discrimination Lear | 1984 |
[Digestive symptoms in the course of benzodiazepine withdrawal syndrome].
Topics: Anxiety Disorders; Bromazepam; Diarrhea; Drug Therapy, Combination; Female; Gastrointestinal Motilit | 1994 |
[Benzodiazepine withdrawal presenting as pseudo-surgical abdominal pain].
Topics: Abdomen, Acute; Adult; Alprazolam; Anti-Anxiety Agents; Bromazepam; Diagnosis, Differential; Headach | 1997 |
Generalized tonic-clonic seizures following withdrawal of therapeutic dose of bromazepam.
Topics: Anti-Anxiety Agents; Bromazepam; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Humans; Mid | 1999 |
Benzodiazepine withdrawal-induced catatonia.
Topics: Anti-Anxiety Agents; Bromazepam; Catatonia; Electroencephalography; Humans; Male; Middle Aged; Subst | 2001 |
Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Body Weight; Brain; Brain Chemistry; B | 1977 |
Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam.
Topics: Animals; Anti-Anxiety Agents; Brain; Bromazepam; Diazepam; Humans; Hydroxyindoleacetic Acid; Male; M | 1977 |
Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1, 4-benzodiazepines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Brain; Brain Chemistry; Bromazepam; Di | 1978 |
Substitution of psychoactive drugs in pentobarbital-dependent rats.
Topics: Animals; Antidepressive Agents; Arousal; Body Weight; Brain; Bromazepam; Bupropion; Diazepam; Dose-R | 1990 |